Zylox-Tonbridge’s Breakthrough Medical Device Approval

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190) has released an update.

Zylox-Tonbridge Medical Technology Co., Ltd. has announced that its ZYLOX Unicorn® Suture-mediated Closure System has been approved for marketing by the National Medical Products Administration, breaking the import brand monopoly in vascular puncture solution markets. This innovative device, which is expected to enhance the safety and efficiency of vascular surgeries, is part of the company’s portfolio of 44 products approved in China and additional products certified in the European Union and other global markets. The launch promises to offer a high-quality, affordable medical technology that could benefit more patients with reduced complication risks and recovery times.

For further insights into HK:2190 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.